B-Type natriuretic peptides and mortality after stroke a systematic review and meta-Analysis

Neurology

Volumn 81, Issue 23, 2013, Pages 1976-1985

  García Berrocoso, Teresa ^a   Giralt, Dolors ^a   Bustamante, Alejandro ^a   Etgen, Thorleif ^b,c   Jensen, Jesper K ^d   Sharma, Jagdish C ^e   Shibazaki, Kensaku ^f   Saritas, Ayhan ^g   Chen, Xingyong ^h   Whiteley, William N ⁱ   Montaner, Joan ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Klinikum Traunstein   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f KAWASAKI MEDICAL SCHOOL   (Japan)

^g DUZCE UNIVERSITY   (Turkey)

^h FUJIAN MEDICAL UNIVERSITY   (China)

ⁱ UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE;

AGE DISTRIBUTION; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; EMBASE; FATALITY; HUMAN; MEDLINE; META ANALYSIS; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX RATIO; STROKE PATIENT; SYSTEMATIC REVIEW;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; NATRIURETIC PEPTIDE, BRAIN; STROKE;

EID: 84892423056     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436937.32410.32     Document Type: Review

References (39)

1. Saposnik G, Kapral MK, Liu Y, et al. IScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation 2011;123:739-749
2. O'Donnell MJ, Fang J, D'Uva C, et al. The PLAN Score: a bedside prediction rule for death and severe disability following acute ischemic stroke. Arch Intern Med 2012; 172:1548-1556
3. Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke 2009;40:e380-e389
4. Whiteley W, Jackson C, Lewis S, et al. Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. PLoS Med 2009;6:e1000145
5. deLemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet 2003;362:316-322
6. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-328
7. Mäkikallio AM, Mäkikallio TH, Korpelainen JT, et al. Natriuretic peptides and mortality after stroke. Stroke 2005;36:1016-1020
8. Jensen JK, Mickley H, Bak S, Korsholm L, Kristensen SR. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis 2006;22:439-444
9. Shibazaki K, Kimura K, Okada Y, et al. Plasma brain natriuretic peptide as an independent predictor of in-hospital mortality after acute ischemic stroke. Intern Med 2009;48:1601-1606
10. Whiteley W, Wardlaw J, Dennis M, et al. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke. Stroke 2012;43:86-91
11. Montaner J, García-Berrocoso T, Mendioroz M, et al. Brain natriuretic peptide is associated with worsening and mortality in acute stroke patients but adds no prognostic value to clinical predictors of outcome. Cerebrovasc Dis 2012;34:240-245
12. Januzzi JL Jr, Maisel AS, Silver M, Xue Y, DeFilippi C. Natriuretic peptide testing for predicting adverse events following heart failure hospitalization. Congest Heart Fail 2012;18:S9-S13
13. Coutance G, Le Page O, Lo T, Hamon M. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care 2008;12:R109
14. Garcia-Berrocoso T, Giralt D, Bustamante A, Montaner J. B-type natriuretic peptides (BNP and NT-proBNP) blood levels as biomarkers for all-cause mortality after stroke: a systematic review, meta-analysis and pooled-data analysis. PROSPERO 2012:CRD42012003284. Available at: http://www.crd.york.ac.uk/PROSPERO/display-record asp?ID=CRD42012003284#. Umou6HDWMil. Accessed October 2013
15. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6:e1000097
16. Duval S, Tweedie R. Trim and fill: a simple funnel-plotbased method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455-463
17. Efron B, Tibshirani R. An introduction to the bootstrap. In: Cox DR, Hinkley DV, Reid N, Rubin DB, Silverman BW, editors. Monographs on Statistics and Applied Probability. New York: Chapman & Hall/CRC; 1993
18. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-845
19. Pencina MJ, D'Agostino RB, D'Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172
20. Etgen T, Baum H, Sander K, Sander D. Cardiac troponins and N-terminal pro-brain natriuretic peptide in acute ischemic stroke do not relate to clinical prognosis. Stroke 2005;36:270-275
21. Sharma JC, Ananda K, Ross I, Hill R, Vassallo M. N-terminal probrain natriuretic peptide levels predict short-term poststroke survival. J Stroke Cerebrovasc Dis 2006;15:121-127
22. Koenig MA, Puttgen HA, Prabhakaran V, Reich D, Stevens RD. B-type natriuretic peptide as a marker for heart failure in patients with acute stroke. Intensive Care Med 2007;33:1587-1593
23. Modrego PJ, Boned B, Berlanga JJ, Serrano M. Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci 2008;5:18-23
24. Idris I, Hill R, Ross I, Sharma JC. N-terminal probrain natriuretic peptide predicts 1-year mortality following acute stroke: possible evidence of occult cardiac dysfunction among patients with acute stroke. Age Ageing 2010; 39:752-755
25. Cakir Z, Saritas A, Emet M, Aslan S, Akoz A, Gundogdu F. A prospective study of brain natriuretic peptide levels in three subgroups: stroke with hypertension, stroke without hypertension, and hypertension alone. Ann Indian Acad Neurol 2010;13:47-51
26. Üstündaǧ M, Orak M, Güloǧlu C, Öztürk E, Tamam Y, Kale E. The role of serum ferritin, pro-brain natriuretic peptide and homocysteine levels in determining ischaemic stroke subtype, severity and mortality. J Emerg Med 2010; 17:13-21
27. Shibazaki K, Kimura K, Iguchi Y, Aoki J, Sakai K, Kobayashi K. Plasma brain natriuretic peptide predicts death during hospitalization in acute ischaemic stroke and transient ischaemic attack patients with atrial fibrillation. Eur J Neurol 2011;18:165-169
28. Rost N, Biffi A, Cloonan L, et al. Brain natriuretic peptide predicts functional outcome in ischemic stroke. Stroke 2012;43:441-445
29. Hajdinjak E, Klemen P, Grmec Š. Prognostic value of a single prehospital measurement of N-terminal pro-brain natriuretic peptide and troponin T after acute ischaemic stroke. J Int Med Res 2012;40:768-776
30. Chen X, Zhan X, Chen M, et al. The prognostic value of combined NT-pro-BNP levels and NIHSS scores in patients with acute ischemic stroke. InternMed 2012;51:2887-2892
31. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418-422
32. Riley RD, Lambert PC, Abo-Zaid G. Meta-analysis of individual participant data: rationale, conduct, and reporting. BMJ 2010;340:c221
33. McCullough PA, Omland T, Maisel AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003;4:72-80
34. Kim SH, Lee JY, Park SH, et al. Plasma B-type natriuretic peptide level in patients with acute cerebral infarction according to infarction subtype and infarction volume. Int J Med Sci 2013;10:103-109
35. Sharma JC, Ross I, Vassallo M. Cardio-protection in acute stroke. Int J Stroke 2007;2:288-290
36. Montaner J, Perea-Gainza M, Delgado P, et al. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-2287
37. Santamarina E, Penalba A, García-Berrocoso T, et al. Biomarker level improves the diagnosis of embolic source in ischemic stroke of unknown origin. J Neurol 2012;259: 2538-2545
38. Vuolteenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease. Adv Clin Chem 2005;40:1-36
39. Srisawasdi P, Vanavanan S, Charoenpanichkit C, Kroll MH. The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J Clin Pathol 2010; 133:14-23